Inhibition of Src/FAK signaling downstream of collagen IV attenuated chemotherapy-induced cancer cell migration, providing insights into mechanisms by which cytotoxic treatments may augment the metastatic potential of residual disease [84]. This evidence concerns the gene PTK2 and cancer.